Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

about

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

Item

http://www.wikidata.org/entity/Q48324081

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@en

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@nl

type

Item

label

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@en

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@nl

prefLabel

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@en

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

@nl

P1476

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus

@en

P2093

Bertram Wiedenmann

http://www.w3.org/2001/XMLSchema#string

Heinz-Josef Klümpen

http://www.w3.org/2001/XMLSchema#string

Marianne Pavel

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.

Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas.

Are G3 ENETS neuroendocrine neoplasms heterogeneous?

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.

Everolimus in Pancreatic Neuroendocrine Carcinomas G3.

P304

686-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1398410

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timm Denecke

Cansu G Genç

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29126357

http://www.w3.org/2001/XMLSchema#string